US Remains Non-committal
on India's Move to Get TRIPS Waiver to COVID Vaccines at WTO
US
Trade Representatives Katherine Tai, in her address to the World Trade Organisation (WTO) virtual conference on COVID-19 vaccine
equity on Wednesday, however, did not weigh in on the request made by India and
South Africa.
The
US remained non-committal on the move by India and South Africa to get
Trade-Related Aspects of Intellectual Property Rights (TRIPS) waiver for COVID-19 vaccine
before the WTO so that the doses are
accessible and affordable to low- and middle-income countries.
The
move by India, South Africa and several other countries has been supported by
more than 60 top American lawmakers, most of whom are progressives.
US
Trade Representatives Katherine Tai, in her address to the World Trade Organisation
(WTO) virtual conference on COVID-19 vaccine equity on Wednesday, however, did
not weigh in on the request made by India and South Africa.
The
virtual conference was attended and addressed by her Indian counterpart Piyush Goyal,
Executive Vice President Valdis Dombrovskis of the European Union, and
Minister Ebrahim Patel of South Africa on Wednesday.
“I
have had a chance already to have very meaningful preliminary conversations
with each of you. I am committed to finding ways to partner with you on the
issues before us today and more broadly,” Tai said.
Acknowledging
that there is still a gaping divide between developed and developing countries
when it comes to access to medicines, she said that this was seen during the
HIV/AIDS epidemic, where various policies and actions constrained access to
medicines, contributing to unnecessary deaths and suffering.
“We
must learn from, and not repeat, the tragedies and mistakes of the past. The
Doha Declaration on the TRIPS Agreement and Public Health, for example, was
born out of the HIV/AIDS crisis, and we all – both in government and in the
private sector – need to do our parts to live up to its spirit,” Tai said.
But
there are many aspects of the institution of the WTO and its rules that have
not adapted to a changed world, a changed membership, changed practices and
expectations.
“We
must ensure that this time of crisis and suffering leads to breakthroughs and
progress,” Tai said in her address.
“We
hope to hear more today about how the market once again has failed in meeting
the health needs of developing countries. As part of that we have to consider
what modifications and reforms to our trade rules might be necessary to reflect
what we have learned,” she said.
Later
at the end of the conference, WTO Director General Ngozi
Okonjo-Iweala said the speakers agree that it's not
acceptable for people and countries to have to wait indefinitely for vaccines.
“We
do not want to repeat experiences of the past,” she said.
“It
was agreed that production capacity needs to be expanded, particularly in
developing and least developed countries and emerging markets. And that vaccine
distribution needs to be more effective and more equitable,” Okonjo-Iweala said.
“Various
perspectives about the TRIPS agreement, and whether the existing flexibilities
are enough to address developing country needs were put on the table. These
echoed the discussions on the waiver proposal going on in the TRIPS Council,
and I want to reiterate that today is a way of contributing to that
discussion,” she said.
“I
agree with the view that the WTO is a logical forum for finding a way forward
on these issues, and I hope that the ideas raised here will contribute to
convergence in the TRIPS Council on meaningful results that can contribute to
the goals that we have,” WTO Director General said.
In a
statement, Peter Maybarduk, director of Public
Citizen's Access to Medicines, demanded that the US should support the TRIPS
waiver.
“Despite
US support for COVAX, it
will be difficult to earn goodwill if the United States continues to block
partner countries' efforts to make medical tools. The US should support the TRIPS
Waiver and step in with leadership to make vaccines for the billions of people
who are still waiting," he said.
“The
US should support the efforts of partner nations to protect their people and
expand access to COVID
treatments, tests, protective equipment and vaccines, by endorsing the
temporary suspension of the WTO intellectual property rules proposed by South
Africa and India,” Maybarduk said.